Cytek Biosciences to Participate in Upcoming Investor Conferences
07 févr. 2024 16h10 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
07 févr. 2024 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the fourth...
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
17 janv. 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek Biosciences has signed an agreement with The Centre for Genomic Regulation and the Pompeu Fabra University to accelerate scientific discoveries.
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
08 janv. 2024 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the...
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
28 déc. 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
21 déc. 2023 09h00 HE
|
Cytek Biosciences, Inc.
The new Cytek Orion reagent cocktail preparation system simplifies & accelerates laboratory workflow, assures consistent experimental results & saves time.
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
14 nov. 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
08 nov. 2023 09h00 HE
|
Cytek Biosciences, Inc.
The Cytek® Aurora™ CS system has been selected as the “Cell Sorting Product of the Year” in the third annual BioTech Breakthrough Awards program.
Cytek Biosciences Reports Third Quarter 2023 Financial Results
07 nov. 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
19 oct. 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third...